Betting on the Genome: Anthropic Acquires Biotech Startup Coefficient Bio for $400M

Artificial General Intelligence (AGI) models are giving way to highly specialized Expert AI. On April 3, 2026, a major M&A deal was revealed: Anthropic is acquiring the startup Coefficient Bio for $400 million.

This is not just an acqui-hire; it is buying a stake in the multi-billion dollar life sciences market. Pharmaceutical giants don't need chatbots to generate text; they need algorithms for protein folding, predictive toxicology, and the synthesis of new molecules. Coefficient Bio possesses closed databases of medical and biological data (the proprietary datasets that enterprises pay for). By integrating this data into the Claude architecture, Anthropic is forming a powerful B2B offering for the healthcare industry, diversifying its revenue amidst fierce competition with Microsoft and OpenAI.

Source: TechCrunch / The Information